0000950170-24-026593.txt : 20240305 0000950170-24-026593.hdr.sgml : 20240305 20240305194744 ACCESSION NUMBER: 0000950170-24-026593 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240302 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cuneo Andrew CENTRAL INDEX KEY: 0001848186 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39695 FILM NUMBER: 24723696 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viatris Inc CENTRAL INDEX KEY: 0001792044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834364296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: (724) 514-1465 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: Upjohn Inc DATE OF NAME CHANGE: 20191023 4 1 ownership.xml 4 X0508 4 2024-03-02 0001792044 Viatris Inc VTRS 0001848186 Cuneo Andrew 1000 MYLAN BOULEVARD CANONSBURG PA 15317 false true false false See Remarks false Common Stock 2024-03-02 4 M false 17372 0.00 A 52167 D Common Stock 2024-03-02 4 F false 7890 12.59 D 44277 D Common Stock 2024-03-02 4 M false 7348 0.00 A 51625 D Common Stock 2024-03-02 4 F false 3259 12.59 D 48366 D Common Stock 2024-03-02 4 M false 972 0.00 A 49338 D Common Stock 2024-03-02 4 F false 432 12.59 D 48906 D Common Stock 2024-03-03 4 M false 12579 0.00 A 61485 D Common Stock 2024-03-03 4 F false 5579 12.59 D 55906 D Common Stock 2024-03-03 4 M false 620 0.00 A 56526 D Common Stock 2024-03-03 4 F false 275 12.59 D 56251 D Common Stock 2024-03-04 4 M false 6291 0.00 A 62542 D Common Stock 2024-03-04 4 F false 2791 12.36 D 59751 D Common Stock 2024-03-04 4 M false 547 0.00 A 60298 D Common Stock 2024-03-04 4 F false 243 12.36 D 60055 D Performance Restricted Stock Units 0.00 2024-03-02 4 A false 17372 0.00 A Common Stock 17372 17372 D Performance Restricted Stock Units 0.00 2024-03-02 4 M false 17372 0.00 D Common Stock 17372 0 D Restricted Stock Units 0.00 2024-03-02 4 M false 7348 0.00 D Common Stock 7348 0 D Dividend Equivalent Units 0.00 2024-03-02 4 M false 971.4053 0.00 D Common Stock 971.4053 0 D Restricted Stock Units 0.00 2024-03-03 4 M false 12579 0.00 D Common Stock 12579 25157 D Dividend Equivalent Units 0.00 2024-03-03 4 M false 619.0319 0.00 D Common Stock 619.0319 1239 D Restricted Stock Units 0.00 2024-03-04 4 M false 6291 0.00 D Common Stock 6291 6291 D Dividend Equivalent Units 0.00 2024-03-04 4 M false 546.7635 0.00 D Common Stock 546.7635 547 D Restricted Stock Units 0.00 2024-03-04 4 A false 35397 0.00 A Common Stock 35397 35397 D Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 2, 2021. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021. Fractional shares have been rounded up in connection with the settlement described in footnote 15 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2023. Fractional shares have been rounded up in connection with the settlement described in footnote 17 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 3, 2023. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022. Fractional shares have been rounded up in connection with the settlement described in footnote 19 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022. Amount includes DEUs that accrued with respect to the PRSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Each PRSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). The PRSUs were initially granted on March 2, 2021, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 2, 2024. Each RSU represents the right to receive one share of common stock of Viatris. 7,348 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022, March 2, 2023 and March 2, 2024. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Each RSU represents the right to receive one share of common stock of Viatris. 12,579 of the RSUs granted on March 3, 2023 vested on March 3, 2024, 12,578 will vest on March 3, 2025 and 12,579 will vest on March 3, 2026. Represents DEUs that accrued with respect to the RSUs previously granted on March 3, 2023 and vest on the same schedule as the underlying RSUs. Each RSU represents the right to receive one share of common stock of Viatris. 6,291 of the RSUs granted on March 4, 2022 vested on each of March 4, 2023 and March 4, 2024 and 6,291 will vest on March 4, 2025. Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. Each RSU represents the right to receive one share of common stock of Viatris. The RSUs vest in three equal annual installments beginning on March 4, 2025. President, JANZ (Japan, Australia and New Zealand) and Emerging Markets /s/ Kevin Macikowski, by power of attorney 2024-03-05